Auto-immune

Delve into the world of Auto-immune in China’s pharmaceutical industry. Fineline Info & Tech provides reliable data, news, and insights on Auto-immune to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Roche Reports Positive Phase II Topline Data for Enicepatide – Once‑Weekly GLP‑1/GIP Agonist Cuts HbA1c by 2.65% and Body Weight by 15.5% at 48 Weeks
CompanyDrug

Roche Reports Positive Phase II Topline Data for Enicepatide – Once‑Weekly GLP‑1/GIP Agonist Cuts HbA1c by 2.65% and Body Weight by 15.5% at 48 Weeks

Roche Holding AG (SWX: ROP; OTCMKTS: RHHBY) announced positive topline results from CT‑388‑104, a Phase II clinical trial evaluating enicepatide (CT‑388) in adults living with type 2 diabetes (T2D) and…

BMS Plans 265 Princeton Layoffs – Bristol Myers Squibb Extends Its USD 2 Billion Cost Cutting Drive

BMS Plans 265 Princeton Layoffs – Bristol-Myers Squibb Extends Its USD 2 Billion Cost Cutting Drive

Tangzhi Pharma Secures Nearly RMB 100 Million Exclusive Financing from Fengnian Capital – Glyco Raw‑Material Platform Targets ADC and Nucleic‑Acid Drug Boom

Tangzhi Pharma Secures Nearly RMB 100 Million Exclusive Financing from Fengnian Capital – Glyco Raw‑Material Platform Targets ADC and Nucleic‑Acid Drug Boom

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
MabPharm's CMAB807 Biosimilar Infliximab Approved in Pakistan
CompanyDrug

MabPharm’s CMAB807 Biosimilar Infliximab Approved in Pakistan

NMPA Grants Conditional Approval for China's First MSCs Therapy for aGVHD
CompanyDrug

NMPA Grants Conditional Approval for China’s First MSCs Therapy for aGVHD

Prime Gene Therapeutics Secures Over RMB300 Million in Series B Financing
CompanyDeals

Prime Gene Therapeutics Secures Over RMB300 Million in Series B Financing

MabPharm's CMAB807 Biosimilar Receives Market Approval in Indonesia and Peru
CompanyDrug

MabPharm’s CMAB807 Biosimilar Receives Market Approval in Indonesia and Peru

Johnson & Johnson Secures Licensing Deal with Kaken Pharmaceutical for STAT6 Program
CompanyDeals

Johnson & Johnson Secures Licensing Deal with Kaken Pharmaceutical for STAT6 Program

Henlius Biotech Expands Partnership with Palleon Pharmaceuticals for Autoimmune Disease Treatment
CompanyDeals

Henlius Biotech Expands Partnership with Palleon Pharmaceuticals for Autoimmune Disease Treatment

Everest Medicines' Velsipity NDA for Ulcerative Colitis Accepted by China's NMPA
CompanyDrug

Everest Medicines’ Velsipity NDA for Ulcerative Colitis Accepted by China’s NMPA

Johnson & Johnson Submits sBLA to FDA for Simponi in Pediatric Ulcerative Colitis
CompanyDrug

Johnson & Johnson Submits sBLA to FDA for Simponi in Pediatric Ulcerative Colitis

Show More